Dehns has been working with Green Biologics since 2006, when the company was just Dr Green (the founder) and five scientists. The relationship started when Dehns Partner, Philip Webber, met Dr Green at an industry event. Following further meetings, Philip was asked to draft and file Green Biologics's first patent applications relating to the genetic engineering of bacteria to make butanol.
Watch our short video on how Dehns has assisted Green Biologics in using their IP to leverage finance.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.